Literature DB >> 25279202

Learning curve of endorectal ultrasonography in preoperative staging of rectal carcinoma.

Zuo-Liang Liu1, Tong Zhou1, Xiao-Bo Liang2, Jun-Jie Ma2, Guang-Jun Zhang1.   

Abstract

Accurate preoperative staging of rectal carcinoma is essential for optimal treatment. This study was designed to evaluate the accuracy and learning curve of endorectal ultrasonography (ERUS) in the preoperative staging of rectal carcinoma. We retrospectively analyzed the records of patients with rectal carcinoma who underwent preoperative ERUS followed by curative surgery at the Shanxi Province Tumor Hospital between January, 2007 and March, 2010. The patients were divided into three groups, namely A, B and C, depending on whether the examination was performed between January and December, 2007, between January and December, 2008 or between January, 2009 and March, 2010, respectively. Five physicians with no prior experience in ERUS performed the examinations. We compared the ERUS staging with the pathological findings using the tumor-node-metastasis (TNM) classification. The accuracy of ERUS in T and N staging after each additional consecutive 20 patients was calculated for physicians D, E and F. A total of 319 patients underwent ERUS prior to surgery. There were 38 patients in group A, 135 in group B and 146 in group C. Two of the five physicians performed only 47 of the 319 examinations, whereas the remaining 272 patients were examined by physicians D (n=162), E (n=64) and F (n=46). The overall accuracy in assessing the extent of rectal wall invasion (T) was 67%, with 16% of the cases overstaged and 17% understaged and the accuracy in assessing nodal involvement (N) was 66%, with 11% of the cases overstaged and 23% understaged. The total T and N staging accuracy of physicians D, E and F was 75 and 72%; 59 and 59%; and 50 and 52%, respectively. For physicians D, E and F, the accuracy of T and N staging after each additional 20 patients was calculated and the curve of the accuracy reached a plateau after physician D completed 80 cases. Therefore, ERUS is a valuable tool for assessing the depth of tumor invasion and it appears that after ~80 cases a physician may be considered able to apply it efficiently.

Entities:  

Keywords:  accuracy; endorectal ultrasonography; learning curve; rectal carcinoma; staging; tumor invasion

Year:  2014        PMID: 25279202      PMCID: PMC4179823          DOI: 10.3892/mco.2014.352

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  25 in total

1.  Morphology of lymph nodes in the resected rectum of patients with rectal carcinoma.

Authors:  O Dworak
Journal:  Pathol Res Pract       Date:  1991-12       Impact factor: 3.250

2.  Endorectal ultrasonography for the assessment of wall invasion and lymph node metastasis in rectal cancer.

Authors:  Y Katsura; K Yamada; T Ishizawa; H Yoshinaka; H Shimazu
Journal:  Dis Colon Rectum       Date:  1992-04       Impact factor: 4.585

3.  The endosonic appearances of normal colon and rectum.

Authors:  J Beynon; D M Foy; L N Temple; J L Channer; J Virjee; N J Mortensen
Journal:  Dis Colon Rectum       Date:  1986-12       Impact factor: 4.585

4.  Does a learning curve exist in endorectal two-dimensional ultrasound accuracy?

Authors:  O J Morris; B Draganic; S Smith
Journal:  Tech Coloproctol       Date:  2011-07-09       Impact factor: 3.781

5.  Lymph node size and metastatic infiltration in colon cancer.

Authors:  S P Mönig; S E Baldus; T K Zirbes; W Schröder; D G Lindemann; H P Dienes; A H Hölscher
Journal:  Ann Surg Oncol       Date:  1999-09       Impact factor: 5.344

6.  [Staging rectal cancer].

Authors:  J R Ayuso Colella; M Pagés Llinás; C Ayuso Colella
Journal:  Radiologia       Date:  2010 Jan-Feb

7.  EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study.

Authors:  Glòria Fernández-Esparrach; Juan R Ayuso-Colella; Oriol Sendino; Mario Pagés; Miriam Cuatrecasas; Maria Pellisé; Joan Maurel; Carmen Ayuso-Colella; Begoña González-Suárez; Josep Llach; Antoni Castells; Angels Ginès
Journal:  Gastrointest Endosc       Date:  2011-08       Impact factor: 9.427

8.  Pitfalls and sources of error in staging rectal cancer with endorectal us.

Authors:  J B Kruskal; R A Kane; S M Sentovich; H E Longmaid
Journal:  Radiographics       Date:  1997 May-Jun       Impact factor: 5.333

Review 9.  Can endoscopic ultrasound predict early rectal cancers that can be resected endoscopically? A meta-analysis and systematic review.

Authors:  Srinivas R Puli; Matthew L Bechtold; Jyotsna B K Reddy; Abhishek Choudhary; Mainor R Antillon
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

10.  Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer.

Authors:  Bjørn Steinar Nedrebø; Kjetil Søreide; Morten Tandberg Eriksen; Jan Terje Kvaløy; Jon Arne Søreide; Hartwig Kørner
Journal:  Acta Oncol       Date:  2012-10-29       Impact factor: 4.089

View more
  4 in total

1.  Endorectal ultrasound in the identification of rectal tumors for transanal endoscopic surgery: factors influencing its accuracy.

Authors:  Xavier Serra-Aracil; Ana Gálvez; Laura Mora-López; Pere Rebasa; Sheila Serra-Pla; Anna Pallisera-Lloveras; Carla Zerpa; Oriol Moreno; Salvador Navarro-Soto
Journal:  Surg Endosc       Date:  2017-12-21       Impact factor: 4.584

Review 2.  Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians.

Authors:  Eric Van Cutsem; Henk M W Verheul; Patrik Flamen; Philippe Rougier; Regina Beets-Tan; Rob Glynne-Jones; Thomas Seufferlein
Journal:  Cancers (Basel)       Date:  2016-08-31       Impact factor: 6.639

Review 3.  Role of ultrasound in colorectal diseases.

Authors:  Renáta Bor; Anna Fábián; Zoltán Szepes
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

Review 4.  Transrectal ultrasonography of anorectal diseases: advantages and disadvantages.

Authors:  Min Ju Kim
Journal:  Ultrasonography       Date:  2014-11-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.